Dr Reddys Laboratories (RDY) Free Cash Flow (2009 - 2026)

Dr Reddys Laboratories has reported Free Cash Flow for 17 years, with the latest figure at $26.4 million in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 89.49% year-over-year to $26.4 million in Q2 2026; TTM through Jun 2026 was $717.2 million, a 12.25% decrease from a year earlier, with the FY2026 full-year figure at $907.3 million, up 4.65% from the prior year.
• Free Cash Flow was $26.4 million for Q2 2026 at Dr Reddys Laboratories, down from $238.5 million in the prior quarter.
• The five-year high for Free Cash Flow was $318.9 million in Q4 2022, with the low at $26.4 million in Q2 2026.
• Average Free Cash Flow over 5 years is $190.4 million, with a median of $191.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Free Cash Flow jumped 3940.38% in 2022, then tumbled 89.49% in 2026.
• Over 5 years, Free Cash Flow stood at $318.9 million in 2022, then sank by 67.72% to $103.0 million in 2023, then surged by 95.42% to $201.2 million in 2024, then rose by 18.52% to $238.5 million in 2025, then plunged by 88.93% to $26.4 million in 2026.
• The last three Free Cash Flow figures came in at $26.4 million (Q2 2026), $238.5 million (Q3 2025), and $251.1 million (Q2 2025), per Business Quant data.